Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-HA Antibodies as Correlate of Protection in H1N1 Challenge
NCT01971255Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2013
- Primary completion
- Sep 2015
- Modality
- Oncolytic Viruses, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of influenza a/bethesda/mm2/h1n1 in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Sep 2013; status: completed.
02
Drugs
influenza a/bethesda/mm2/h1n1
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01971255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01971255.